For example, postmortem investigation of patients with AD showed that GLT-1 was expressed more in activated astrocytes, and cognitive functions were preserved better before the patient’s death (Kobayashi et al., 2018). The gene discussed is SLC1A2; the disease is Alzheimer disease.